Non-invasive PGT-A might be the next wave in preimplantation genetic testing, offering similar results to biopsy-based PGT-A without the need to invasively biopsy the embryo to achieve results. PGT-A has been shown to improve pregnancy and live-birth rates, decrease miscarriage rates and decrease time to pregnancy for women undergoing IVF treatment. Can non-invasive PGT-A offer the same benefits? Is non-invasive PGT-A ready for use in patients today? What do we know about the DNA we find in spent culture media? Do you have to change your embryology system to accommodate non-invasive PGT-A?
In this webinar, Dr. Gary Harton will review the current status of PGT-A and non-invasive PGT-A and will detail some of the work that PerkinElmer has already done during development of the PG-Seq Rapid Non-Invasive PGT-A kit.